CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the 2017 William Blair Growth Stock Conference in Chicago on Tuesday,
June 13, 2017. The presentation will be delivered by Hany
Massarany, President and Chief Executive Officer, and is scheduled
for 3:30 p.m. (CT). The presentation will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care, improve
key quality metrics, and reduce the total cost-of-care. Utilizing
GenMark's proprietary eSensor® detection technology, GenMark's eSensor
XT- 8® and ePlex® systems are designed to support a broad range of
molecular diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. GenMark's ePlex®: The
True Sample-to-Answer Solution™ is designed to optimize laboratory
efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal
infections. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170531006495/en/
GenMark Diagnostics, Inc.
Hany Massarany
President, Chief
Executive Officer
760-448-4325
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media
